Now, researchers from the Women's and Children's Hospital, Adelaide have developed a novel system of gene therapy for lungs affected by cystic fibrosis, involving a natural compound found in our lungs which 'conditions' lung airways to allow cells to take up the therapeutic gene.
Our lungs have developed highly effective ways to protect us from allergens, irritants, dust, viruses and other foreign particles. But according to principal medical scientist in Pulmonary Medicine, Dr David Parsons these defences also hinder effective gene therapy in our lungs.
"Using a mouse model of cystic fibrosis Maria Limberis, a PhD student in our lab, has helped us develop a system to briefly overcome these defences. As the cells lining the mouse nose behave in much the same way as human lung cells this enables us to use the nose airways in mice to easily develop and test out gene therapy treatments.
"By instilling a single dose of a detergent found naturally in low amounts in our lungs, we are able to 'condition' cells to take up the gene needed to treat cystic fibrosis.
" Viruses are very good at transferring their genetic material into cells and we make use of this by getting useful parts of an inactive and highly-modified human immunodeficiency virus type 1 (HIV 1) to safely transfer the cystic fibrosis gene into cells. We use this modified HIV because it is one of the few viruses that can give long-lasting gene transfer," Dr Parsons says.
Using this system, the research team has shown, for the first time in a living animal, that long-lived gene therapy for cystic fibrosis is possible. Not only do the airway cells take up the correcting gene, but these cells also show substantial recovery from the cystic
Contact: Dr Edna Bates
Women's and Children's Hospital, Adelaide - Part of the Children, Youth and Women's Health Service